Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 1999

View Archived Issues

Favorable data presented for PEGASYS in HCV therapy

Glaxo Wellcome launches first drug to treat PPH in Japan

ImClone highlights Q1 1999 progress with cancer products

Therapeutic Antibodies reports advances in product development in Q1 1999

Progress in key development programs reported by Cantab

Novel epoxysuccinamide derivatives for bone diseases/arthritis developed at Nippon Chemiphar

Hokuriku Seiyaku claims new thiourea antibacterial agents

Muscarinic antagonists from Tokyo Tanabe particularly useful for respiratory disorders

Merck presents new 8a-azalides and their use in the treatment of bacterial infections

BASF describes new, selective ECE inhibitors

K1-5 is a more potent angiogenesis inhibitor than angiostatin

Tetrahydrofurans as 5-HT2 receptor antagonists: synthesis and preliminary pharmacological evaluation

Novel series from Dr. Reddy for diabetes, hyperlipidemia, etc.

Merck closes in on oral oxytocin antagonist for use in preterm labor

Corixa, Zambon collaborate to develop lung cancer immunotherapeutic vaccines

Addition of BTI-322 to tacrolimus immunosuppression decreases incidence of transplant rejection

L-770644: potent and selective human beta3-adrenoceptor agonist with good oral bioavailability

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

MDX-447 shows promising biological activity in phase I/II trial, results reported at ASCO meeting

SkyePharma announces U.S. launch of DepoCyt

Axcan's Protectaid contraceptive sponge approved in Italy

Abgenix MAb shows promise in GVHD following stem cell transplantation and heads for pivotal trials

Alteon to seek new partner for continued pimagedine development

C225 demonstrates high efficacy and good tolerance in two types of carcinomas

Cortex receives SBIR grant for new stroke therapy

FDA approves Vioxx for osteoarthritis, acute pain and menstrual pain

Adenosine A1 antagonist prevents ischemia-reperfusion injury in the liver

Chinese Kampo medicine is effective and safe in the treatment of bowel obstruction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...